INBRX-106 | Interleukin Related interleukin-related.com

Product Name :
INBRX-106

Search keywords :
OX40L

drugId :
null

Target Vo:
Tumor necrosis factor receptor superfamily member 4

Target Vo Short Name :
OX40

Moa_Name:
Tumor necrosis factor receptor superfamily member 4 agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Inhibrx

Active Company_Name :
Elpiscience Biopharma Ltd

Active Indication_Name:
Squamous Cell Carcinoma of Head and Neck

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
SATB2 Antibody
Aquaporin 5 Antibody
Pyruvate Dehydrogenase E1 alpha Antibody (YA681): Pyruvate Dehydrogenase E1 alpha Antibody (YA681) is a non-conjugated and Mouse origined monoclonal antibody about 43 kDa, targeting to Pyruvate Dehydrogenase E1 alpha (3H2). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts